Kakao Healthcare, a subsidiary of Korea’s internet conglomerate Kakao, said on Tuesday that it signed a business agreement with Novo Nordisk, a Danish multinational healthcare firm, to provide smart healthcare services for Korean patients with diabetes.Under the agreement, the two companies will lin
Medical device software accounted for 61 percent of all designated innovative medical devices through last month.The Ministry of Food and Drug Safety said it is exploring ways for innovative medical devices to enjoy advantages in public tenders.The ministry said Friday that it has designated 13 prod
A forum is in store to examine the rapidly developing medical artificial intelligence (AI) and digital therapeutic devices (DTx) fields.Kakao Healthcare said it would host the “2023 Global Digital Healthcare Symposium” with Yonsei University Health System (YUHS) on Aug. 30. The symposium is designed
Osstem Implant, a dental equipment and supplies manufacturer, said it would voluntarily delist from the Kosdaq market on Aug. 14, 16 years after the company started trading on the tech-heavy secondary stock market,Korea Exchange finalized the delisting of Osstem after deliberations by the Corporate
Noul, an AI-based blood and cancer diagnostic platform company, has signed an exclusive agreement worth about $5.18 million (6.6 billion won) with a Nigerian medical device wholesaler to supply its digital microscopy platform until 2026. It was the company's third exclusive supply contract since its
Bertis, a company specializing in developing proteomics-based precision medicine technology, said it has launched PASS (Pan-omics Analysis Service & Solution) service in the U.S. through its local subsidiary, Bertis Bioscience.Bertis Bioscience has prepared to launch the PASS services after more tha
Next&Bio, a company specializing in organoid-based drug discovery, said on Monday that its pancreatic cancer drug susceptibility test has been designated an innovative medical technology. The company said that the test had become Korea’s first organoid-based innovative medical technology, paving the
CJ Bioscience said on Friday that it plans to launch its microbiome analysis platform, EzBiome Bioinformatics App (EzBiome), next year.Since July, the company has been conducting a pilot service of EzBiome by opening some functions to bio-industry officials and university professors. On Wednesday, t
Kakao Healthcare has taken the first step toward building a data-driven leading model for clinical trials.Kakao Healthcare said Thursday that a consortium it formed with Kyung Hee Medical Center has been selected as a research conductor to develop new technologies for smart clinical trials. The cons
Coreline Soft said on Friday that inquiries for its AVIEW Pseudomyzation Sever are increasing in response to the Ministry of Health and Welfare (MOHW) announcement to strengthen medical data security policies.While the digitalization of the medical industry has advanced the quality of medical servic
Philips Korea emphasized its intention to zone in on the rising Generation Z as a key consumer group for their 2030 Philips Personal Health plans to expand its consumer base in the Korean market.Philips Personal Health Korea held a press conference on Wednesday at the Plaza Hotel in Seoul.“Philips a
Roche Diagnostics Korea said on Wednesday that two of its Alzhimer’s disease cerebrospinal fluid (CSF) tests won approval from the Ministry of Food and Drug Safety (MFDS). The two tests were approved by the U.S. FDA in December 2022.The Elecsys β-Amyloid (1-42) CSF II (Abeta42) and Elecsys Phospho-T
Lunit, a Korean medical AI company, said on Wednesday that it signed a commercial contract with Cloud Solutions, a Saudi-based subsidiary of Dr. Sulaiman Al Habib Medical Group (HMG), to supply its AI mammography solution, Lunit INSIGHT MMG.This follows the collaboration with Seha Virtual Hospital,
Korean medical artificial intelligence (AI) imaging companies are being placed on the Korea Exchange (KRX)’s investment caution list one after another as their stock prices continues to surge abnormally this year.Most recently, the KRX placed JLK on the investment caution list last Thursday and Frid
NGeneBio said on Monday that it established a fully owned U.S. subsidiary called NGeneBioAI which will operate as an AI precision diagnosis software company.The subsidiary is expected to serve as a bridgehead for NGeneBio to tap into the U.S. cancer diagnosis market valued at approximately $4.1 bill
Lunit said Friday it has signed a contract with the National Police Hospital (NPH) to supply Lunit Insight CXR, an artificial intelligence image analysis solution for chest X-rays.Lunit Insight CXR is software that utilizes AI-based technology to assist medical professionals by reading 10 chest dise
Boditech Med Inc. said it has received an emergency use authorization (EUA) from the U.S. Food and Drug Administration for Swab-N-Go Home Test COVID-19 Ag, an at-home Covid-19 diagnostic kit.The company has tried to get the EUA through Immunostics, its U.S. subsidiary, for the past year. It plans to
Waycen’s artificial intelligence solution to help gastric cancer diagnosis has been designated as an innovative medical device.The Ministry of Food and Drug Safety (MFDS) said Wednesday that it has designated Waycen’s gastric cancer image detection and diagnosis aid software, WAYMED Endo ST CS, as t
Novomics, a cancer diagnostics company, has patented a genetic prognostic technology for rectal cancer in Korea, the company said on Friday. The technology can screen high-risk rectal cancer patients who are more likely to have recurrences based on the molecular subtypes of their cancer.In particula
Korea’s DTx market launched in earnest with the domestic approval of two cognitive-based treatment (CBT) digital therapeutics (DTx) for treating insomnia -- Aimmed’s Somzz and Welt’s Pillowbot in February and April, respectively.According to a report released on Tuesday by the Korea Innovative Medic